CFTR and cystic fibrosis: The mechanism by which CFTR dysfunction relates to gut dysmotility is unknown, but it has been hypothesised that CF may be linked to alterations in eicosanoid metabolism, resulting in increased levels of prostaglandin E2 that may exert inhibitory effects on enteric smooth muscle [74].